Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin R Bailey

Showing results (11-20 of 83) with videos related to

Pageof 9
Sort By:
The Journal of Experimental Medicine|May 10, 2006
Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutationsJustin R Bailey, Thomas M Williams, Robert F Siliciano, et al.
AIDS (London, England)|October 29, 2010
Raltegravir-induced cerebellar ataxiaKim A Reiss, Justin R Bailey, Paul A Pham, et al.
Plos Pathogens|July 15, 2006
Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cellsKara G Lassen, Kasra X Ramyar, Justin R Bailey, et al.
Structure (London, England : 1993)|February 3, 2026
Structural repertoire of HCV broadly neutralizing antibodies targeting the E2 front layer supersiteXander E Wilcox, Rajat Punia, Jessica Mimms, et al.
Journal of Virology|December 14, 2007
Role of APOBEC3G/F-mediated hypermutation in the control of human immunodeficiency virus type 1 in elite suppressorsShiv K Gandhi, Janet D Siliciano, Justin R Bailey, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 30, 2018
Standardized Method for the Study of Antibody Neutralization of HCV Pseudoparticles (HCVpp)Justin R Bailey, Richard A Urbanowicz, Jonathan K Ball, et al.
Journal of Virology|October 24, 2008
Evidence of CD8+ T-cell-mediated selective pressure on human immunodeficiency virus type 1 nef in HLA-B*57+ elite suppressorsJustin R Bailey, Timothy P Brennan, Karen A O'Connell, et al.
Biorxiv : the Preprint Server for Biology|August 13, 2025
Structural Repertoire of HCV Broadly Neutralizing Antibodies Targeting the E2 Front Layer SupersiteXander E Wilcox, Rajat Punia, Jessica Mimms, et al.
Elife|March 4, 2020
An ultralong CDRH2 in HCV neutralizing antibody demonstrates structural plasticity of antibodies against E2 glycoproteinAndrew I Flyak, Stormy E Ruiz, Jordan Salas, et al.
Frontiers in Cellular and Infection Microbiology|April 9, 2020
Combined Effects of HLA-B*57/5801 Elite Suppressor CD8+ T Cells and NK Cells on HIV-1 ReplicationMegan E May, Christopher W Pohlmeyer, Abena K Kwaa, et al.
Pageof 9

Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
The Journal of Experimental Medicine|May 10, 2006
Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutationsJustin R Bailey, Thomas M Williams, Robert F Siliciano, et al.
AIDS (London, England)|October 29, 2010
Raltegravir-induced cerebellar ataxiaKim A Reiss, Justin R Bailey, Paul A Pham, et al.
Plos Pathogens|July 15, 2006
Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cellsKara G Lassen, Kasra X Ramyar, Justin R Bailey, et al.
Structure (London, England : 1993)|February 3, 2026
Structural repertoire of HCV broadly neutralizing antibodies targeting the E2 front layer supersiteXander E Wilcox, Rajat Punia, Jessica Mimms, et al.
Journal of Virology|December 14, 2007
Role of APOBEC3G/F-mediated hypermutation in the control of human immunodeficiency virus type 1 in elite suppressorsShiv K Gandhi, Janet D Siliciano, Justin R Bailey, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 30, 2018
Standardized Method for the Study of Antibody Neutralization of HCV Pseudoparticles (HCVpp)Justin R Bailey, Richard A Urbanowicz, Jonathan K Ball, et al.
Journal of Virology|October 24, 2008
Evidence of CD8+ T-cell-mediated selective pressure on human immunodeficiency virus type 1 nef in HLA-B*57+ elite suppressorsJustin R Bailey, Timothy P Brennan, Karen A O'Connell, et al.
Biorxiv : the Preprint Server for Biology|August 13, 2025
Structural Repertoire of HCV Broadly Neutralizing Antibodies Targeting the E2 Front Layer SupersiteXander E Wilcox, Rajat Punia, Jessica Mimms, et al.
Elife|March 4, 2020
An ultralong CDRH2 in HCV neutralizing antibody demonstrates structural plasticity of antibodies against E2 glycoproteinAndrew I Flyak, Stormy E Ruiz, Jordan Salas, et al.
Frontiers in Cellular and Infection Microbiology|April 9, 2020
Combined Effects of HLA-B*57/5801 Elite Suppressor CD8+ T Cells and NK Cells on HIV-1 ReplicationMegan E May, Christopher W Pohlmeyer, Abena K Kwaa, et al.
Pageof 9